An Antibody-Aptamer-Hybrid Lateral Flow Assay for Detection of CXCL9 in Antibody-Mediated Rejection after Kidney Transplantation

An Antibody-Aptamer-Hybrid Lateral Flow Assay for Detection of CXCL9 in Antibody-Mediated Rejection after Kidney Transplantation

Chronic antibody-mediated rejection (AMR) is a key limiting factor for the clinical outcome of a kidney transplantation (Ktx), where early diagnosis and therapeutic intervention is needed. This study describes the identification of the biomarker CXC-motif chemokine ligand (CXCL) 9 as an indicator fo...

Full description

Bibliographic Details
Main Authors:	Lisa K. Seiler, Ngoc Linh Phung, Christoph Nikolin, Stephan Immenschuh, Christian Erck, Jessica Kaufeld, Hermann Haller, Christine S. Falk, Rebecca Jonczyk, Patrick Lindner, Stefanie Thoms, Julia Siegl, Günter Mayer, Regina Feederle, Cornelia A. Blume
Format:	Article
Language:	English
Published:	MDPI AG 2022-01-01
Series:	Diagnostics
Subjects:	biomarkers antibody-mediated rejection (AMR) neural net analysis CXCL9 (MIG) aptamer antibody
Online Access:	https://www.mdpi.com/2075-4418/12/2/308

Similar Items

CXCL12 Neutralizing Antibody Promotes Hair Growth in Androgenic Alopecia and Alopecia Areata
by: Mei Zheng, et al.
Published: (2024-01-01)

Anti-complement 5 antibody ameliorates antibody-mediated rejection after liver transplantation in rats
by: Tetsuya Tajima, et al.
Published: (2023-06-01)

IgY antibodies: The promising potential to overcome antibiotic resistance
by: Sherif A. El-Kafrawy, et al.
Published: (2023-01-01)

The effect of transplantation of cultured autologous melanocytes on CXCL9, CXCL10 and CXCL11 expressions in vitiligo
by: Chen Xu, et al.
Published: (2023-01-01)

Prevalence and risk factors of antibodies towards HLA Class I and Class II in Malaysian renal transplant candidates
by: Norfarhana Khairul-Fahmy, et al.
Published: (2023-02-01)

Characteristics of Immunoglobulin M Type Antibodies of Different Origins from the Immunologic and Clinical Viewpoints and Their Application in Controlling Antibody-Mediated Allograft Rejection
by: Yoshiko Matsuda, et al.
Published: (2020-12-01)

Establishment and Functional Characterization of Murine Monoclonal Antibodies Recognizing Neuritin
by: Georgia Papadogianni, et al.
Published: (2023-04-01)

Complement Binding Anti-HLA Antibodies and the Survival of Kidney Transplantation
by: Claudia M. Muñoz-Herrera, et al.
Published: (2023-03-01)

Heparin-Independent and Heparin-Dependent Anti-CXCL4 Antibodies Have a Reciprocal Expression in a Systemic Sclerosis Patients’ Cohort
by: Raffaella Palazzo, et al.
Published: (2022-12-01)

Catalytic antibodies /
by: Keinan, Ehud
Published: (2005)

Prediction of antigen-responding VHH antibodies by tracking the evolution of antibody along the time course of immunization
by: Tomonari Matsuda, et al.
Published: (2024-01-01)

antibodies in ancient Iraq
by: abdullatif AL-Badri
Published: (2005-07-01)

Principles and Current Clinical Landscape of Multispecific Antibodies against Cancer
by: Mariam Elshiaty, et al.
Published: (2021-05-01)

Extracellular vesicles: a potential new player in antibody-mediated rejection in lung allograft recipients
by: Sandhya Bansal, et al.
Published: (2023-09-01)

Design of antibody variable fragments with reduced reactivity to preexisting anti-drug antibodies
by: Maria U. Johansson, et al.
Published: (2023-12-01)

PREPARATION AND PROPERTIES OF MURINE ANTI-IDIOTYPIC MONOCLONAL ANTIBODIES RECOGNIZING PRIMARY RABBIT POLYCLONAL ANTIBODIES AGAINST MORPHINE DERIVATIVES
by: A. V. Trofimov, et al.
Published: (2019-12-01)

Differential Anti-Tumor Effects of IFN-Inducible Chemokines CXCL9, CXCL10, and CXCL11 on a Mouse Squamous Cell Carcinoma Cell Line
by: Ari Matsumoto, et al.
Published: (2023-04-01)

Vaccinal antibodies: Fc antibody engineering to improve the antiviral antibody response and induce vaccine-like effects
by: Dhuha H Nawab
Published: (2021-12-01)

Antibodies, Nanobodies, or Aptamers—Which Is Best for Deciphering the Proteomes of Non-Model Species?
by: Poshmaal Dhar, et al.
Published: (2020-04-01)

Novel Human Bispecific Aptamer–Antibody Conjugates for Efficient Cancer Cell Killing
by: Margherita Passariello, et al.
Published: (2019-08-01)

Monoclonal antibodies : the second generation /
by: 186276 Zola, Heddy
Published: (1995)

Antibody engineering : methods and protocols /
by: Lo, Benny K. C.
Published: (2004)

Monoclonal Antibodies and Antibody Drug Conjugates in Multiple Myeloma
by: Jakub Radocha, et al.
Published: (2021-03-01)

Bispecific antibodies for viral immunotherapy
by: Elisabeth K. Nyakatura, et al.
Published: (2017-04-01)

Antibody engineering /
by: Kontermann, Roland, et al.
Published: (2001)

Monoclonal antibodies /
by: Peter, J. H., et al.
Published: (1992)

Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications
by: Riham Ayoubi, et al.
Published: (2023-11-01)

Generation of hapten-specific recombinant antibodies: antibody phage display technology: a review
by: J. Brichta, et al.
Published: (2005-06-01)

Interactions of the chemokines CXCL11 and CXCL12 in human tumor cells
by: Christian Koch, et al.
Published: (2022-12-01)

Idiotype-antiidiotypic interaction of antibodies in the bloodstream
by: S. A. Bobrovnik
Published: (2014-04-01)

Commentary: Brief report - Monoclonal antibodies illustrate the difficulties in measuring blocking TSH receptor antibodies
by: Paul D. Olivo, et al.
Published: (2022-10-01)

Advances in the progress of monoclonal antibodies for rabies
by: Linlin Fan, et al.
Published: (2022-01-01)

Emerging Role of Antibody-Drug Conjugates and Bispecific Antibodies for the Treatment of Multiple Myeloma
by: Waqqas Tai, et al.
Published: (2022-03-01)

Recent Progress in Development and Application of DNA, Protein, Peptide, Glycan, Antibody, and Aptamer Microarrays
by: G. M. Aparna, et al.
Published: (2023-03-01)

Large-scale production of monoclonal antibodies in suspension culture /
by: 271860 Backer, M. P., et al.

Process scale purification of antibodies /
by: Gottschalk, Uwe
Published: (2009)

Can antibodies be “vegan”? A guide through the maze of today’s antibody generation methods
by: Stefan Dübel
Published: (2024-12-01)

Recombinant antibodies for immunotherapy /
by: Little, Melvyn
Published: (2009)

Biparatopic antibodies: therapeutic applications and prospects
by: David L. Niquille, et al.
Published: (2024-12-01)

Spectroscopic studies of AFP, Anti AFP antibody and AFP/125I- anti AFP antibody complex.
by: Bilal Jasir Mohammed, et al.
Published: (2014-02-01)